4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank88
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-164.43%
↑ 100% vs avg
Percentile
P88
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-48960.43%
Historical baseline
PeriodValueYoY Change
2025-164.43%+100.0%
2024-434778.38%-89251.3%
2023-486.59%+85.8%
2022-3435.41%-768.9%
2021-395.37%+5.1%
2020-416.49%+41.0%
2019-705.78%-944.2%
2018-67.59%+65.1%
2017-193.83%-